Testosterone Stroke

Published on September 23, 2014 by Sandy Liebhard

Text-Size:A A A+

More than 2.3 million men in the U.S. were prescribed AndroGel and other hormone-raising prescription therapies in 2013, which may raise questions about the number of people who may be unknowingly at risk for a testosterone heart attack or stroke.

testosterone strokeLast year, the manufacturer of AndroGel garnered $1.04 billion in sales of the medication, while Auxilium Pharmaceuticals, Inc. took in $271 million in sales of its Testim gel. As 2013 came to a close, however, a study published in JAMA: The Journal of the American Medical Association found an increased risk of strokes, heart attacks and other serious cardiovascular problems in men being treated with testosterone products. Results of the November 2013 analysis have now preceded dozens of lawsuits alleging testosterone strokes, heart attacks, and other cardiovascular injuries, which plaintiffs allege they were inadequately warned about by manufacturers.

The attorneys at Bernstein Liebhard LLP are actively evaluating testosterone lawsuits on behalf of men who were injured by prescription testosterone therapies and may be eligible to receive compensation for damages. Call the Firm’s attorneys for more about testosterone strokes at .

Testosterone Stroke

In November 2013, JAMA: Internal Medicine revealed that 33 men out of 1,223 who underwent prescription testosterone therapy suffered a testosterone stroke. 67 deaths were also recorded, according to the JAMA research, which also noted that annual prescriptions for these products increased by more than 5-fold between 2000 and 2011. In 2011, that translated to 5.3 million prescriptions written, and $1.6 million in market earnings.

The U.S. Food and Drug Administration (FDA) has not taken these findings lightly. A federal agency alert on January 31, 2014 warned about the possible association between testosterone products and the risk for strokes, deep vein thrombosis, blood clots and other cardiovascular injuries. At the time, regulators announced that they would be investigating safety of the following medications:

  • AndroGel
  • Axiron
  • Androderm
  • Depo-Testosterone
  • Striant
  • Bio-T-Gel
  • Delatestryl
  • Fortesta
  • Testopel

Also in January, research published in the medical journal, PLoS One, found an increased risk of testosterone heart attacks in younger men with a pre-existing heart problems and all men older than 65.

Testosterone side effects have since been alleged in dozens of lawsuits now filed in the U.S. District Court, Northern District of Illinois. According to claims, testosterone drug manufacturers failed to warn about risks associated with their products in order to protect sales.

Did You Suffer a Testosterone Stroke? Contact Us.

Call our Firm to learn more about the risk of testosterone stroke, heart attack, and other problems allegedly due to testosterone therapies. Contact our Firm today: .